Medicare and Medicaid Programs; Continued Approval of the American Diabetes Association as an Accrediting Organization for Diabetes Self-Management Training Programs, 57825-57826 [2015-24358]

Download as PDF Federal Register / Vol. 80, No. 186 / Friday, September 25, 2015 / Notices 1865(a)(2) of the Act and our regulations at § 410.142 and § 410.143, we conducted a review of AADE’s national accreditation organization based on the criteria set forth in § 410.142(b), which include, but are not limited to the following: (1) A review of the national accreditation organization’s operations and office to verify information in the organization’s application and assess the organization’s compliance with its own policies and procedures; (2) evaluating accreditation results or the accreditation status decision making process; and (3) interviewing the organization’s staff. The April 24, 2015 proposed notice also solicited public comments on the ability of AADE to continue to develop standards that meet or exceed the Medicare conditions for coverage and apply them to entities furnishing outpatient services. We received no public comments in response to our proposed notice. IV. Provisions of the Final Notice AADE’s application to continue as an accredited NAO to deem entities for the purposes of DSMT is approved for a period of 6 years. The accreditation is effective on September 25, 2015. This approval is subject to renewal subsequent to the receipt of an application from the AADE and subject to review, evaluation, and approval of its program. Based on our review and observations described in section II of this final notice, we approve AADE as a national accreditation organization for entities furnishing DSMT that request participation in the Medicare program, effective September 25, 2015 through September 27, 2021. V. Collection of Information Requirements mstockstill on DSK4VPTVN1PROD with NOTICES This document does not impose information collection requirements, that is, reporting, recordkeeping or third-party disclosure requirements. Consequently, there is no need for review by the Office of Management and Budget under the authority of the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.). Dated: September 16, 2015. Andrew M. Slavitt, Acting Administrator, Centers for Medicare & Medicaid Services. [FR Doc. 2015–24357 Filed 9–24–15; 8:45 am] BILLING CODE 4120–01–P VerDate Sep<11>2014 19:58 Sep 24, 2015 Jkt 235001 57825 SUMMARY: This final notice announces our decision to approve the American Diabetes Association (ADA) for continued recognition as a national accreditation program for accrediting entities that wish to furnish outpatient diabetes self-management training (DSMT) to Medicare beneficiaries. DATES: This final notice is effective September 25, 2015 through September 27, 2021. FOR FURTHER INFORMATION CONTACT: Kristin Shifflett, (410) 786–4133; Jacqueline Leach, (410) 786–4282. SUPPLEMENTARY INFORMATION: We may approve and recognize a nonprofit organization with demonstrated experience in representing the interests of individuals with diabetes to accredit entities to furnish DSMT. The accreditation organization, after being approved and recognized by CMS, may accredit an entity to meet one of the sets of quality standards in § 410.144 (Quality standards for deemed entities). Section 1865(a)(2) of the Social Security Act (the Act) requires that we review the applying accreditation organization’s requirements for accreditation, as follows: • Survey procedures. • Ability to provide adequate resources for conducting required surveys. • Ability to supply information for use in enforcement activities. • Monitoring procedures for providers found out of compliance with the conditions or requirements. • Ability to provide CMS with necessary data for validation. We then examine the NAO’s accreditation requirements to determine if they meet or exceed the Medicare conditions as we would have applied them. I. Background II. Application Approval Process Under the Medicare program, eligible beneficiaries may receive outpatient diabetes self-management training (DSMT) when ordered by the physician (or qualified non-physician practitioner) treating the beneficiary’s diabetes, provided certain requirements are met by the provider. Pursuant to our regulations at 42 CFR 410.141(e)(3), we use national accrediting organizations (NAOs) to assess whether provider entities meet Medicare requirements when providing DSMT services for which Medicare payment is made. If a provider entity is accredited by an approved accrediting organization, it is ‘‘deemed’’ to meet applicable Medicare requirements. A NAO must meet the standards and requirements specified by the Secretary of the Department of Health and Human Services in our regulations under part 410, subpart H, to qualify for deeming authority. The regulations pertaining to application procedures for NAOs for DSMT are specified at § 410.142 (CMS process for approving NAOs). A NAO applying for deeming authority must provide us with reasonable assurance that the accrediting organization requires accredited entities to meet requirements that are at least as stringent as our requirements. Section 1865(a)(3)(A) of the Act provides a statutory timetable to ensure that our review of applications for CMSapproval of an accreditation program is conducted in a timely manner. The Act provides us 210 days after the date of receipt of a complete application, with any documentation necessary to make the determination, to complete our survey activities and application process. Within 60 days after receiving a complete application, we must publish a notice in the Federal Register that identifies the national accrediting body making the request, describes the request, and provides no less than a 30day public comment period. At the end of the 210-day period, we must publish a notice in the Federal Register approving or denying the application. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–3316–FN] Medicare and Medicaid Programs; Continued Approval of the American Diabetes Association as an Accrediting Organization for Diabetes Self-Management Training Programs Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Final notice. AGENCY: PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 III. Provisions of the Proposed Notice On April 30, 2015, we published a proposed notice in the Federal Register (80 FR 24253) entitled ‘‘Application by the American Diabetes Association for Continued Deeming Authority for Diabetes Self-Management Training,’’ announcing the receipt of an application from the ADA for continued recognition as a national accreditation program for accrediting entities that wish to furnish outpatient DSMT to Medicare beneficiaries. E:\FR\FM\25SEN1.SGM 25SEN1 57826 Federal Register / Vol. 80, No. 186 / Friday, September 25, 2015 / Notices In that notice, we detailed our evaluation criteria. Under section 1865(a)(2) of the Act and our regulations at § 410.142 and § 410.143, we conducted a review of ADA’s NAO based on the criteria set forth in § 410.142(b), which include, but are not limited to the following: (1) A review of the NAO’s operations and office to verify information in the organization’s application and assess the organization’s compliance with its own policies and procedures; (2) evaluating accreditation results or the accreditation status decision making process; and (3) interviewing the organization’s staff. The April 30, 2015 proposed notice also solicited public comments on the ability of ADA to continue to develop standards that meet or exceed the Medicare conditions for coverage and apply them to accredit entities to furnish training. We received no public comments in response to our proposed notice. IV. Provisions of the Final Notice ADA’s application to continue as an accredited NAO to deem entities for the purposes of DSMT is approved for a period of 6 years. The accreditation is effective on September 25, 2015. This approval is subject to renewal subsequent to the receipt of an application from the ADA and subject to review, evaluation, and approval of its program. Based on our review and observations described in section III of this final notice, we approve ADA as a NAO for entities furnishing DSMT that request participation in the Medicare program, effective September 25, 2015 through effective September 27, 2021. V. Collection of Information Requirements mstockstill on DSK4VPTVN1PROD with NOTICES This document does not impose information collection requirements, that is, reporting, recordkeeping or third-party disclosure requirements. Consequently, there is no need for review by the Office of Management and Budget under the authority of the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.). Dated: September 17, 2015. Andrew M. Slavitt, Acting Administrator, Centers for Medicare & Medicaid Services. [FR Doc. 2015–24358 Filed 9–24–15; 8:45 am] BILLING CODE 4120–01–P VerDate Sep<11>2014 19:58 Sep 24, 2015 Jkt 235001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifiers: CMS–10519 and CMS–10583] Agency Information Collection Activities: Proposed Collection; Comment Request Centers for Medicare & Medicaid Services, HHS. ACTION: Notice. AGENCY: SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (the PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Comments must be received by November 24, 2015. ADDRESSES: When commenting, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in any one of the following ways: 1. Electronically. You may send your comments electronically to https:// www.regulations.gov. Follow the instructions for ‘‘Comment or Submission’’ or ‘‘More Search Options’’ to find the information collection document(s) that are accepting comments. 2. By regular mail. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention: Document Identifier/OMB Control Number ____, Room C4–26–05, DATES: PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 7500 Security Boulevard, Baltimore, Maryland 21244–1850. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, you may make your request using one of following: 1. Access CMS’ Web site address at https://www.cms.hhs.gov/Paperwork ReductionActof1995. 2. Email your request, including your address, phone number, OMB number, and CMS document identifier, to Paperwork@cms.hhs.gov. 3. Call the Reports Clearance Office at (410) 786–1326. FOR FURTHER INFORMATION CONTACT: Reports Clearance Office at (410) 786– 1326. SUPPLEMENTARY INFORMATION: Contents This notice sets out a summary of the use and burden associated with the following information collections. More detailed information can be found in each collection’s supporting statement and associated materials (see ADDRESSES). CMS–10519 Physician Quality Reporting System (PQRS) and the Electronic Prescribing Incentive (eRx) Program Data Assessment, Accuracy and Improper Payments Identification Support CMS–10583 Data Collection for Medicare Beneficiaries Receiving Beta Amyloid Positron Emission Tomography (PET) for Dementia and Neurodegenerative Disease Under the PRA (44 U.S.C. 3501– 3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term ‘‘collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA requires federal agencies to publish a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice. Information Collection 1. Type of Information Collection Request: Revision of a currently approved collection; Title of Information Collection: Physician E:\FR\FM\25SEN1.SGM 25SEN1

Agencies

[Federal Register Volume 80, Number 186 (Friday, September 25, 2015)]
[Notices]
[Pages 57825-57826]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-24358]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[CMS-3316-FN]


Medicare and Medicaid Programs; Continued Approval of the 
American Diabetes Association as an Accrediting Organization for 
Diabetes Self-Management Training Programs

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.

ACTION: Final notice.

-----------------------------------------------------------------------

SUMMARY: This final notice announces our decision to approve the 
American Diabetes Association (ADA) for continued recognition as a 
national accreditation program for accrediting entities that wish to 
furnish outpatient diabetes self-management training (DSMT) to Medicare 
beneficiaries.

DATES: This final notice is effective September 25, 2015 through 
September 27, 2021.

FOR FURTHER INFORMATION CONTACT: Kristin Shifflett, (410) 786-4133; 
Jacqueline Leach, (410) 786-4282.

SUPPLEMENTARY INFORMATION: 

I. Background

    Under the Medicare program, eligible beneficiaries may receive 
outpatient diabetes self-management training (DSMT) when ordered by the 
physician (or qualified non-physician practitioner) treating the 
beneficiary's diabetes, provided certain requirements are met by the 
provider. Pursuant to our regulations at 42 CFR 410.141(e)(3), we use 
national accrediting organizations (NAOs) to assess whether provider 
entities meet Medicare requirements when providing DSMT services for 
which Medicare payment is made. If a provider entity is accredited by 
an approved accrediting organization, it is ``deemed'' to meet 
applicable Medicare requirements.
    A NAO must meet the standards and requirements specified by the 
Secretary of the Department of Health and Human Services in our 
regulations under part 410, subpart H, to qualify for deeming 
authority. The regulations pertaining to application procedures for 
NAOs for DSMT are specified at Sec.  410.142 (CMS process for approving 
NAOs).
    A NAO applying for deeming authority must provide us with 
reasonable assurance that the accrediting organization requires 
accredited entities to meet requirements that are at least as stringent 
as our requirements.
    We may approve and recognize a nonprofit organization with 
demonstrated experience in representing the interests of individuals 
with diabetes to accredit entities to furnish DSMT. The accreditation 
organization, after being approved and recognized by CMS, may accredit 
an entity to meet one of the sets of quality standards in Sec.  410.144 
(Quality standards for deemed entities).
    Section 1865(a)(2) of the Social Security Act (the Act) requires 
that we review the applying accreditation organization's requirements 
for accreditation, as follows:
     Survey procedures.
     Ability to provide adequate resources for conducting 
required surveys.
     Ability to supply information for use in enforcement 
activities.
     Monitoring procedures for providers found out of 
compliance with the conditions or requirements.
     Ability to provide CMS with necessary data for validation.
    We then examine the NAO's accreditation requirements to determine 
if they meet or exceed the Medicare conditions as we would have applied 
them.

II. Application Approval Process

    Section 1865(a)(3)(A) of the Act provides a statutory timetable to 
ensure that our review of applications for CMS-approval of an 
accreditation program is conducted in a timely manner. The Act provides 
us 210 days after the date of receipt of a complete application, with 
any documentation necessary to make the determination, to complete our 
survey activities and application process. Within 60 days after 
receiving a complete application, we must publish a notice in the 
Federal Register that identifies the national accrediting body making 
the request, describes the request, and provides no less than a 30-day 
public comment period. At the end of the 210-day period, we must 
publish a notice in the Federal Register approving or denying the 
application.

III. Provisions of the Proposed Notice

    On April 30, 2015, we published a proposed notice in the Federal 
Register (80 FR 24253) entitled ``Application by the American Diabetes 
Association for Continued Deeming Authority for Diabetes Self-
Management Training,'' announcing the receipt of an application from 
the ADA for continued recognition as a national accreditation program 
for accrediting entities that wish to furnish outpatient DSMT to 
Medicare beneficiaries.

[[Page 57826]]

    In that notice, we detailed our evaluation criteria. Under section 
1865(a)(2) of the Act and our regulations at Sec.  410.142 and Sec.  
410.143, we conducted a review of ADA's NAO based on the criteria set 
forth in Sec.  410.142(b), which include, but are not limited to the 
following: (1) A review of the NAO's operations and office to verify 
information in the organization's application and assess the 
organization's compliance with its own policies and procedures; (2) 
evaluating accreditation results or the accreditation status decision 
making process; and (3) interviewing the organization's staff.
    The April 30, 2015 proposed notice also solicited public comments 
on the ability of ADA to continue to develop standards that meet or 
exceed the Medicare conditions for coverage and apply them to accredit 
entities to furnish training. We received no public comments in 
response to our proposed notice.

IV. Provisions of the Final Notice

    ADA's application to continue as an accredited NAO to deem entities 
for the purposes of DSMT is approved for a period of 6 years. The 
accreditation is effective on September 25, 2015. This approval is 
subject to renewal subsequent to the receipt of an application from the 
ADA and subject to review, evaluation, and approval of its program.
    Based on our review and observations described in section III of 
this final notice, we approve ADA as a NAO for entities furnishing DSMT 
that request participation in the Medicare program, effective September 
25, 2015 through effective September 27, 2021.

V. Collection of Information Requirements

    This document does not impose information collection requirements, 
that is, reporting, recordkeeping or third-party disclosure 
requirements. Consequently, there is no need for review by the Office 
of Management and Budget under the authority of the Paperwork Reduction 
Act of 1995 (44 U.S.C. 3501 et seq.).

    Dated: September 17, 2015.
Andrew M. Slavitt,
Acting Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 2015-24358 Filed 9-24-15; 8:45 am]
 BILLING CODE 4120-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.